An inquest into a teenager’s death is resulting in calls for new rules on prescription drugs in Canada.
According to a recent article from The Canadian Press, a jury is calling for substantial changes to be made regarding Canadian rules on prescription drugs. The changes are being sought following a recent inquest probing the death of a teenage girl who died while taking a prescription heartburn medication.
The drug in question was Prepulsid and according to the article, it has been linked to at least 90 deaths in Canada and the U.S. Prepulsid is a prescription drug that was approved for use in the symptomatic treatment of gastrointestinal motility disorders, including gastroesophageal reflux disease (GERD). It has been banned in both countries.
Cardiac problems reported to be caused by Prepulsid included: ventricular tachycardia, ventricular fibrillation, QT interval prolongation, torsades de pointes, cardiac arrest and sudden death.
Side effects reportedly caused by Prepulsid included: shortness of breath or difficulty breathing, irregular heartbeat, racing heartbeat, weakness, tiredness, insomnia, nausea and vomiting, diarrhea or constipation, abdominal cramps, headache, stomach pain, coughing, skin rash, incontinence, back pain, vertigo, dizziness, blurred vision.
The teenager was 15.
Medbroadcast: Hamilton inquest into teenager’s death calls for new rules on prescriptions
Yahoo News Canada: Drug distributor was concerned doctors were using Prepulsid incorrectly
Health Canada: Prepulsid to be withdrawn as a result of cardiac complications
—–
Thank you to Dr. Ali R. Akhavan for providing the medbroadcast link.
planetc1.com-news @ 5:39 am | Article ID: 988807190
Comments are closed for this article!